Prions : The New Biology of Proteins
, by Soto, Claudio- ISBN: 9781420040128 | 142004012X
- Cover:
- Copyright: 12/20/2005
Each chapter ends with a concluding summation and references | |
Human and animal diseases: clinical symptoms, epidemiology, and neuropathology | |
Human diseases | |
Animal diseases | |
Variant CJD | |
Neuropathology | |
The infectious agent and the prion hypothesis | |
Hypothesis for the infectious agent | |
Evidence supporting the prion hypothesis | |
Criticisms of the prion hypothesis | |
In vitro generation of prions | |
The prion protein: structure, conversion, and mechanism of propagation | |
Structural features of the cellular and scrapie prion protein isoforms | |
Molecular mechanism of PrPC to PrPSc conversion | |
Other factors involved in PrP conversion | |
Peptide models used to understand PrP structure and conversion | |
Cell biology, genetic and putative function of the normal prion protein | |
Cellular biology of the normal prion protein | |
A signaling role for the prion protein? | |
PrP ligands indicate a potential role in apoptosis | |
A putative role of PrP in copper metabolism | |
PrP knockout animals and doppel | |
Prion strains, species barriers, and multiple conformations of the prion protein | |
Prion strains | |
Species barrier | |
Multiple conformations of PrP | |
From the mouth to the brain | |
Prions in the gastrointestinal tract | |
The immune-system connection | |
From the lymphoid organs to the brain: peripheral nerves or blood-brain barrier? | |
Neurodegeneration in prion diseases | |
Characteristics of brain degeneration | |
Is PrP the cause of TSE neurodegeneration? | |
Mechanism of neuronal apoptosis | |
Neuronal apoptosis in TSEs involves the ER-stress pathway | |
A role for the proteasome in TSE pathogenesis? | |
The diagnosis problem and current tests | |
Importance of early diagnosis | |
Difficulties of diagnosis | |
Current status of TSE diagnosis in humans | |
Postmortem detection of BSE in cattle | |
The need for detection of PrP in blood | |
Novel approaches under development for premortem early diagnosis | |
Spectroscopic techniques | |
Conformational antibodies | |
PrP concentration by binding to specific ligands | |
PrP amplification | |
Therapeutic approaches | |
Targets for TSE therapy | |
Compounds under development for TSE treatment | |
Immunization approach | |
Cyclic amplification of prion protein misfolding: rationale, applications, and perspectives | |
The rationale behind PMCA | |
Applications of PMCA in prion diagnosis | |
In vitro generation of infectious prions by PMCA | |
Application of PMCA to understand the prion replication process | |
Other diseases of protein misfolding | |
Protein misfolding and disease | |
Structural determinants of misfolding and aggregation | |
Mechanism and driving forces in protein misfolding and aggregation | |
Kinetics and intermediates of misfolding and aggregation | |
Interactions between misfolded proteins | |
Prions: a common phenomenon in biology? | |
The yeast prions | |
The inherent infectious nature of misfolded aggregates | |
Why are protein misfolding disorders other than TSE not infectious? | |
How common is the prion phenomenon in nature? | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.